BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24349352)

  • 21. FRET-Based Sorting of Live Cells Reveals Shifted Balance between PLK1 and CDK1 Activities During Checkpoint Recovery.
    Lafranchi L; Müllers E; Rutishauser D; Lindqvist A
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of Polo-like kinase 1 by DNA damage in mitosis. Inhibition of mitotic PLK-1 by protein phosphatase 2A.
    Jang YJ; Ji JH; Choi YC; Ryu CJ; Ko SY
    J Biol Chem; 2007 Jan; 282(4):2473-82. PubMed ID: 17121863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WAC Promotes Polo-like Kinase 1 Activation for Timely Mitotic Entry.
    Qi F; Chen Q; Chen H; Yan H; Chen B; Xiang X; Liang C; Yi Q; Zhang M; Cheng H; Zhang Z; Huang J; Wang F
    Cell Rep; 2018 Jul; 24(3):546-556. PubMed ID: 30021153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NFBD1/KIAA0170 is a chromatin-associated protein involved in DNA damage signaling pathways.
    Xu X; Stern DF
    J Biol Chem; 2003 Mar; 278(10):8795-803. PubMed ID: 12499369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential Cellular Effects of Plk1 Inhibitors Targeting the ATP-binding Domain or Polo-box Domain.
    Shin SB; Woo SU; Yim H
    J Cell Physiol; 2015 Dec; 230(12):3057-67. PubMed ID: 25975351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
    Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
    J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation.
    Koida N; Ozaki T; Yamamoto H; Ono S; Koda T; Ando K; Okoshi R; Kamijo T; Omura K; Nakagawara A
    J Biol Chem; 2008 Mar; 283(13):8555-63. PubMed ID: 18174154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polo-like kinase is required for synaptonemal complex disassembly and phosphorylation in mouse spermatocytes.
    Jordan PW; Karppinen J; Handel MA
    J Cell Sci; 2012 Nov; 125(Pt 21):5061-72. PubMed ID: 22854038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NFBD1/MDC1 stabilizes oncogenic MDM2 to contribute to cell fate determination in response to DNA damage.
    Inoue K; Nakanjishi M; Kikuchi H; Yamamoto H; Todo S; Nakagawara A; Ozaki T
    Biochem Biophys Res Commun; 2008 Jul; 371(4):829-33. PubMed ID: 18471438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of Vimentin Phosphorylation by the Avian Reovirus p17 through Inhibition of CDK1 and Plk1 Impacting the G2/M Phase of the Cell Cycle.
    Chiu HC; Huang WR; Liao TL; Wu HY; Munir M; Shih WL; Liu HJ
    PLoS One; 2016; 11(9):e0162356. PubMed ID: 27603133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replication independent ATR signalling leads to G2/M arrest requiring Nbs1, 53BP1 and MDC1.
    Stiff T; Cerosaletti K; Concannon P; O'Driscoll M; Jeggo PA
    Hum Mol Genet; 2008 Oct; 17(20):3247-53. PubMed ID: 18664457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Akt/protein kinase B-dependent phosphorylation and inactivation of WEE1Hu promote cell cycle progression at G2/M transition.
    Katayama K; Fujita N; Tsuruo T
    Mol Cell Biol; 2005 Jul; 25(13):5725-37. PubMed ID: 15964826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.
    Bower JJ; Karaca GF; Zhou Y; Simpson DA; Cordeiro-Stone M; Kaufmann WK
    Oncogene; 2010 Aug; 29(34):4787-99. PubMed ID: 20562910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Polo-like kinase 1 during the DNA damage response is mediated through loss of Aurora A recruitment by Bora.
    Bruinsma W; Aprelia M; García-Santisteban I; Kool J; Xu YJ; Medema RH
    Oncogene; 2017 Mar; 36(13):1840-1848. PubMed ID: 27721411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Plk1 Polo box domain mediates a cell cycle and DNA damage regulated interaction with Chk2.
    Tsvetkov LM; Tsekova RT; Xu X; Stern DF
    Cell Cycle; 2005 Apr; 4(4):609-17. PubMed ID: 15876876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDC1/NFBD1: a key regulator of the DNA damage response in higher eukaryotes.
    Stucki M; Jackson SP
    DNA Repair (Amst); 2004; 3(8-9):953-7. PubMed ID: 15279781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR.
    Shtivelman E
    Mol Cancer Res; 2003 Nov; 1(13):959-69. PubMed ID: 14638868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks.
    Stucki M; Clapperton JA; Mohammad D; Yaffe MB; Smerdon SJ; Jackson SP
    Cell; 2005 Dec; 123(7):1213-26. PubMed ID: 16377563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mediator of DNA damage checkpoint protein 1 regulates BRCA1 localization and phosphorylation in DNA damage checkpoint control.
    Lou Z; Chini CC; Minter-Dykhouse K; Chen J
    J Biol Chem; 2003 Apr; 278(16):13599-602. PubMed ID: 12611903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.